Semler Scientific (NASDAQ:SMLR) Price Target Raised to $71.00

Semler Scientific (NASDAQ:SMLR) had its price target boosted by Lake Street Capital from $40.00 to $71.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Lake Street Capital’s target price indicates a potential upside of 27.41% from the stock’s previous close.

Semler Scientific Trading Down 8.9 %

Shares of SMLR stock traded down $5.43 during trading hours on Friday, reaching $55.73. The stock had a trading volume of 1,106,436 shares, compared to its average volume of 433,983. The stock’s fifty day simple moving average is $59.91 and its 200 day simple moving average is $39.99. Semler Scientific has a 12 month low of $20.88 and a 12 month high of $81.56. The firm has a market capitalization of $516.57 million, a PE ratio of 27.29 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last announced its earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. The business had revenue of $13.51 million for the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Cerity Partners LLC raised its stake in shares of Semler Scientific by 91.5% during the third quarter. Cerity Partners LLC now owns 1,345,586 shares of the company’s stock worth $31,689,000 after acquiring an additional 642,982 shares in the last quarter. Shariaportfolio Inc. purchased a new position in shares of Semler Scientific during the third quarter worth approximately $3,618,000. AQR Capital Management LLC raised its stake in shares of Semler Scientific by 150.1% during the second quarter. AQR Capital Management LLC now owns 140,498 shares of the company’s stock worth $4,833,000 after acquiring an additional 84,314 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Semler Scientific by 10.5% during the third quarter. Geode Capital Management LLC now owns 135,959 shares of the company’s stock worth $3,202,000 after acquiring an additional 12,964 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in shares of Semler Scientific by 18.3% in the second quarter. Dimensional Fund Advisors LP now owns 126,177 shares of the company’s stock worth $4,341,000 after purchasing an additional 19,552 shares during the last quarter. 49.37% of the stock is owned by hedge funds and other institutional investors.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.